Cardiovascular studies are on the decline
In the arena of drug development, cardiovascular medicine is no longer the favorite therapeutic area. This is according to a study published in the August issue of Nature, which analyzed the number of clinical trials registered at ClinicalTrials registery during the last two years, as reported by heartwire. Cardiology, which used to occupy the top priority position in research and development in the pharmaceutical industry, only now ranked 3rd. The top two places are occupied by cancer oncolgy and neurodegenerative medicine, respectively. This is despite the fact that lipid regulators which brought in US$ 35.2 billion worth of drug sales in 2006. The complete list of the six highest-ranked therapeutic/disease areas is given below:
- Oncology
- CNS disorders
- Cardiology
- Infectious diseases
- Endocrinology
- Respiratory diseases
Raquel Billiones has a PhD in Biology and has over 15 years experience as a researcher, scientific English teacher, and medical writer. Since 2006, she has been a freelance WAHM specializing in medical writing and scientific documentation. 
